The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...
Telomere length and polygenic risk scores (PRS) are linked to idiopathic pulmonary fibrosis (IPF) risk, especially in noncarriers of rare genetic variants. The study identified rare damaging variants ...
Despite the development of cutting-edge genetic testing techniques and considerable progress in our understanding of the genetic basis of idiopathic pulmonary fibrosis (IPF), missing heritability and ...
Researchers identified biomarkers related to the Notch signaling pathway that can aid in the diagnosis of IPF.
There seems to be a causal relationship between genetic susceptibility to idiopathic pulmonary fibrosis (IPF) and hypertension.
The activity levels of four genes linked to the Notch pathway could help in achieving an earlier diagnosis of idiopathic ...
Not intended for US and UK audiencesBI 765423 has been developed to target IL-11, a key driver of fibrosisNew study will investigate potential of ...
ACE inhibitor use was associated with reduced all cause mortality in idiopathic pulmonary fibrosis in a matched real world ...
Hypothyroidism is a significant risk factor for IPF, with a higher prevalence in IPF patients compared to the general population. Mendelian randomization confirmed the association between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results